3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Recruiting
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
1
Prostatic Hyperplasia
1
Interventions
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
1
Urination
1
Transurethral Resection of Prostate
1
Radiotherapy
1
Magnetic Resonance Spectroscopy
1
Finasteride
1
Dutasteride
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Prostatic Hyperplasia
×
Finasteride
×
Clear all
NCT06001619
2023-08-21
PROMED
Turku University Hospital
Phase 4
Recruiting
100 enrolled